Form 4: Pulmonx Corp Executive Rose Geoffrey Beran Sells 1,184 Shares of Common Stock
SEC Form 4 Filing
Rose Geoffrey Beran, Chief Commercial Officer of Pulmonx Corp, sold 1,184 shares of common stock at a price of $9.36 per share on March 22, 2024, according to a Form 4 filing with the SEC.
Summary
- On March 22, 2024, Rose Geoffrey Beran, the Chief Commercial Officer of Pulmonx Corp, sold 1,184 shares of the company's common stock.
- The sale was executed at a price of $9.36 per share.
- Following the transaction, Beran directly owns 307,868 shares of Pulmonx Corp.
- The sale was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on May 24, 2023.
Sentiment
Score: 5
Explanation: The document is a routine SEC filing related to an executive's stock sale. It doesn't inherently convey positive or negative sentiment about the company's performance.
Industry Context
Executive stock sales are a common occurrence in publicly traded companies and are often related to personal financial planning rather than a reflection of the company's prospects.
Stakeholder Impact
- The stock sale may have a minor impact on shareholders due to the small volume of shares sold.
Key Dates
| Date | Description |
|---|---|
| 05/24/2023 | Date the Reporting Person adopted a Rule 10b5-1 trading plan |
| 03/22/2024 | Date of the transaction (stock sale) |
| 03/26/2024 | Date of the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.